Akebia Therapeutics reported $88.4M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 100M Nov/2026
Agios Pharmaceuticals USD 1.61B 598M Nov/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Amgen USD 247.94B 20.06B Nov/2026
Ardelyx USD 718M 542M Nov/2026
Astellas Pharma JPY 4.78T 582.95B Nov/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Bayer EUR 52.42B 5.31B Nov/2026
BioMarin Pharmaceutical USD 10.68B 936M Nov/2026
Celltrion KRW 1.81T 620B Jun/2026
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 2.46B 2.87B Nov/2026
Exelixis USD 19.82B 5.34B Nov/2026
Fresenius Medical Care EUR 12.06B 1.43B Nov/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Ionis Pharmaceuticals USD 4.24B 3.18B Nov/2026
J&J USD 653.61B 42.25B Sep/2026
Kangmei Pharma CNY 16.59B 7.89B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Moderna USD 99.14B 22.26B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 128.48M 74.94M Nov/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pharma Mar EUR 1.17B 85.18M Nov/2026
Prothena USD 437M 76M Nov/2026
Qiagen NV USD 10.01B 2.04B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
Sartorius EUR 17.42B 1.8B Sep/2026
Tectonic Therapeutic USD 649M 69M Jun/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 76.62B 5.43B Nov/2026